Intracervical Anasthesia in Outpatient Hystroscopy, Can Procedure be Completed Diagnostic and Therapeutic With no Need to General Anaesthesia

Not Applicable

Completed

Brief Summary: Single blind randomized controlled study in which 80 patients coming for hystroscopy due to multiple indication as infertility, AUB and missed IUD were assigned for our study. Both Sample size and randomization were done by a computer program. Patients were classified into 2 groups, group 1 study group was subjected to intracervical injection of 5 mi of mepivacaine hydrochloride at position 3 and 9 of the vaginal portion of the cervix, and at least 5 minutes post injection before procedure done. The control group received NSAI injection 15 minutes before procedure and 5 ml of saline was injected in each side of cervix at 3 9 positions. Hystroscopy was done if an abnormality is detected an intervention was done. A descriptive scale of pain was done into mild, moderate or severe (that lead to interruption of the procedures).

Detailed Description: Procedures:

All patients were subjected to:

1. History taking

2. Verbal consent to participate in our study

3. Patient put in lithotomy position

4. Casco speculum was applied exposing the cervix

5. Betadine sterilization of the cervix then properly washed with saline as heavy metals of disinfectant may cause irritation with injection

6. Multiple toothed volselum was used just to fix cervix

7. 3 cartridges of mepivacaine hydrochloride was filled in 10 mi syringe

8. Do aspiration to exclude and avoid intravascular injection then infilterate slowly intracervical at both 3 and 9 positions

9. Instruments are removed and at least 5 minutes later procedure started.

10. Hystroscopy (rigid , 2.9 mm sheath) was introduced gently throw vaginoscopy exploring vagina , cervix and uterine cavity

11. Patient was monitored for pain all through the procedure by descriptive scale, mild, moderate and severe. ( moderate who needed to take rest then continue , severe that necessitated interruption of the procedure

12. All patients were monitored for signs of vaso vagal attack as sings (low blood pressure and bradycardia) before and if needed during. Occurrence of symptoms as pallor , sweet and fainting

13. All patients were monitored post procedure for persistence of colicky pain

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

All patients with history of sever vasovagal attack during any gynecological procedures.

Arm && Interventions

Group	Intervention	Description
study group	study group	patient put in dorsal postion , insertion of a speculum , sterilization of the cervix then intracervical injection of 5 ml mepicaine hydrochloride a local anasthetic as Carbocaine3%54 mg at site 3 and 9 using a 10 cm syringe
control group	control group	patient receives one tablet of NSAIDs (diclofenac sodium 50 mg )15 minutes before procedure then 5 ml of normal saline will be injected intracervical using 10 cm syringe then wait for 5 minutes before the procedure

Primary Outcome Measures

Name	Time	Method
tolerated hystroscopy	30 minutes	complete hystroscopy procedure with tolerable degree of pain.

Secondary Outcome Measures

Name	Time	Method
occurrence of complication	30 minutes	symptoms of vasovagal as vomiting , sweeting and bradycardia

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial